Results 251 to 260 of about 38,538 (308)
Harnessing Tumor Organoids to Revolutionize Immunotherapy Research. [PDF]
Cancer MedWang Z +7 more
europepmc +1 more source
NK cell-mediated tumor cell killing by bispecific innate cell engagers induces ADCC-mediated activation of primary human dendritic cells. [PDF]
OncoimmunologyHeger L +13 more
europepmc +1 more source
A novel bispecific antibody targeting OX40L and TNFα for the targeted treatment of rheumatoid arthritis. [PDF]
Antib TherZhang Q, Song S.
europepmc +1 more source
Bispecific immunotherapy based on antibodies, T-cell receptors, and aptamers: mechanisms of action, adverse effects, and future perspectives. [PDF]
Front ImmunolLopatnikova JA, Sennikov SV.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Engineering bispecific antibodies
Current Opinion in Biotechnology, 1993Bispecific antibodies have immense potential as reagents and in medicine. Until recently, they were made by combining monoclonal antibodies of two different specificities in vitro, or by fusion of the corresponding hybridomas. Protein engineering now offers the chance to construct a range of small 'designer' bispecific antibodies using antibody ...
P, Holliger, G, Winter
openaire +2 more sources
Bispecific Antibodies in Lymphoma
International Reviews of Immunology, 1993Journal Article ; Review ; SCOPUS: ar.j ; info:eu-repo/semantics ...
Brissinck, J +4 more
openaire +2 more sources
Production of Bispecific Antibodies
Current Protocols in Immunology, 1995AbstractBispecific antibodies (bsAbs) contain two different binding specificities within a single molecule and can specifically bind two different molecules together. BsAbs can be produced by chemically cross‐linking purified antibodies or Fab fragments with reducible disulfide bonds or nonreducible thioether bonds, both of which are described in this ...
David M, Segal, Bert J E G, Bast
openaire +2 more sources